CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,629,548 | -19.1% | 498,558 | 0.0% | 12.03% | -63.8% |
| Q2 2023 | $27,989,046 | +24.1% | 498,558 | 0.0% | 33.20% | -29.4% |
| Q1 2023 | $22,549,778 | +11.3% | 498,558 | 0.0% | 47.01% | +12.1% |
| Q4 2022 | $20,266,383 | -37.8% | 498,558 | 0.0% | 41.94% | -24.5% |
| Q3 2022 | $32,581,000 | +7.5% | 498,558 | 0.0% | 55.55% | +19.6% |
| Q2 2022 | $30,297,000 | -3.2% | 498,558 | 0.0% | 46.45% | +48.7% |
| Q1 2022 | $31,294,000 | -17.2% | 498,558 | 0.0% | 31.24% | +54.6% |
| Q4 2021 | $37,781,000 | -32.3% | 498,558 | 0.0% | 20.21% | -12.6% |
| Q3 2021 | $55,804,000 | -32.2% | 498,558 | -2.0% | 23.11% | -15.3% |
| Q2 2021 | $82,330,000 | -56.5% | 508,558 | -67.3% | 27.28% | -26.1% |
| Q1 2021 | $189,472,000 | -59.3% | 1,554,960 | -48.9% | 36.92% | -23.6% |
| Q4 2020 | $465,525,000 | +53.3% | 3,040,462 | -16.3% | 48.34% | -13.0% |
| Q3 2020 | $303,752,000 | -99.9% | 3,631,656 | -13.2% | 55.60% | +25.9% |
| Q2 2020 | $307,413,373,000 | +73.5% | 4,183,064 | -0.5% | 44.16% | -9.1% |
| Q1 2020 | $177,224,616,000 | -30.8% | 4,205,615 | 0.0% | 48.60% | -37.0% |
| Q4 2019 | $256,142,982,000 | +47.6% | 4,205,615 | -0.7% | 77.19% | +15.0% |
| Q3 2019 | $173,546,331,000 | -13.3% | 4,233,870 | -0.4% | 67.15% | +15.2% |
| Q2 2019 | $200,122,625,000 | +31.9% | 4,248,888 | 0.0% | 58.31% | +16.6% |
| Q1 2019 | $151,770,279,000 | +47.2% | 4,248,888 | +17.7% | 50.00% | -2.0% |
| Q4 2018 | $103,105,530,000 | -35.6% | 3,608,874 | 0.0% | 51.04% | -6.2% |
| Q3 2018 | $160,053,562,000 | -24.5% | 3,608,874 | 0.0% | 54.44% | -17.7% |
| Q2 2018 | $212,057,436,000 | +0.7% | 3,608,874 | -21.7% | 66.16% | -1.8% |
| Q1 2018 | $210,551,322,000 | – | 4,606,242 | – | 67.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |